Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats

This publication has 9 references indexed in Scilit:

• Differential Hemodynamic Responses to Selective Inhibitors of Cyclic Nucleotide Phosphodiesterases in Conscious Rats
  Journal of Cardiovascular Pharmacology, 1992
• Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast
  European Journal of Pharmacology, 1991
• Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
  Journal of Clinical Investigation, 1990
• Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY‐5445, vinpocetine and 1‐methyl‐3‐isobutyl‐8‐(methylamino)xanthine
  British Journal of Pharmacology, 1989
• Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta
  British Journal of Pharmacology, 1989
• The guanylate cyclase/receptor family of proteins
  The FASEB Journal, 1989
• Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle
  European Journal of Pharmacology, 1988
• Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976